Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial F-0519-2022

Moor Herbs Healthy Beauty Angel Formula packed in 16oz. plastic containers

Publicado el 19 de enero de 2022 · Inicio del retiro: 23 de diciembre de 2021

Resumen

FDA registra el retiro F-0519-2022 de alimentos de Clase I, publicado el 19 de enero de 2022 e iniciado el 23 de diciembre de 2021. Empresa responsable: MOOR HERBS; Estado: Finalizado; Cantidad reportada: 147 units; Lote: All products. Product does not have any lot code information. La Clase I indica una probabilidad razonable de consecuencias graves para la salud o muerte.

Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

Product is marketed as an infant formula but the required pre-market infant formula notification for this product has not been submitted to the FDA. Product tested by FDA was well above the maximum acceptable range for Iron, Potassium and Sodium, which could potentially lead to iron overload and/or electrolyte imbalances. In addition, the product did not have vitamin D, and a vitamin D deficiency can potentially lead to rickets, a softening and weakening of bones.

Qué hacer

Voluntary: Firm initiated · Letter

Recibe un correo cuando FDA publique un retiro como este

Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.

Detalles del retiro

Fabricante
MOOR HERBS
Distribuidor
Products were distributed via internet sales and through the firm's store-front.
Lote
All products. Product does not have any lot code information.
Clasificación de riesgo
Class I
Área (FDA)
food
País
United States

Retiros relacionados

Preguntas sobre este retiro

¿Moor Herbs Healthy Beauty Angel Formula packed in 16oz. plastic containers fue retirado del mercado?

Sí. FDA publicó el retiro F-0519-2022 el 19 de enero de 2022. Peligro reportado: Product is marketed as an infant formula but the required pre-market infant formula notification for this product has not been submitted to the FDA. Product tested by FDA was well above the maximum acceptable range for Iron, Potassium and Sodium, which could potentially lead to iron overload and/or electrolyte imbalances. In addition, the product did not have vitamin D, and a vitamin D deficiency can potentially lead to rickets, a softening and weakening of bones.

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated · Letter